General Information of Drug (ID: DMAVFG9)

Drug Name
5-Fluoro-2-deoxycytidine
Synonyms FdCyd; 5-Fluoro-2'-deoxycytidine
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C9H12FN3O4
Canonical SMILES
C1C(C(OC1N2C=C(C(=NC2=O)N)F)CO)O
InChI
InChI=1S/C9H12FN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1
InChIKey
IDYKCXHJJGMAEV-RRKCRQDMSA-N
Cross-matching ID
PubChem CID
515328
ChEBI ID
CHEMBL1076257
CAS Number
10356-76-0
UNII
KUA4693H5W
DrugBank ID
DB12957
TTD ID
D0D1LS
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT00978250) A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU). U.S. National Institutes of Health.